Matthew S. Logsdon, MD

Medical Oncologist / Hematologist

Colorado Springs Style Magazine Top Doc 2017
Colorado Springs Style Magazine Top Doc 2020
Matthew S. Logsdon, MD | Rocky Mountain Cancer Centers

Colorado Springs

2312 N Nevada Avenue, Suite 400
Colorado Springs, Colorado 80907

719-577-2555

Request an Appointment

About Matthew S. Logsdon, MD

Dr. Matthew Logsdon is a board-certified medical oncologist and hematologist. He has spent 17 years treating cancer in Colorado Springs. Dr. Logsdon has a strong passion for treating patients in a community-care setting. He has a special interest in gastrointestinal cancers, including pancreatic cancer, stomach cancer, liver cancer, small bowl cancer, colon cancer, and colorectal cancer. A collaborative approach to care is important to Dr. Logsdon’s practice strategy. He is active on gastrointestinal tumor boards, working closely with pathologists, radiologists, surgeons, radiation oncologists, and other subspecialties. In presenting and consulting on cancer cases, Dr. Logsdon can ensure his patients have the benefit of the shared knowledge of multiple cancer experts in planning their treatment options. He has a true passion for treating his patients with compassion and understanding. He strives to provide evidence-based, cutting-edge treatment options to his patients.

Board Certifications

Hematology
Internal Medicine
Medical Oncology

Clinical Care Expertise

Anal Cancer
Biliary Cancer
Bladder Cancer
Breast Cancer
Colorectal Cancer
Head and Neck Cancer
Hematology
Liver Cancer
Lung Cancer
Lymphoma
Medical Oncology
Melanoma
Pancreatic Cancer
Prostate Cancer
Stomach Cancer

Education

Fellowship

Vanderbilt University Medical Center, Nashville, TN

Residency

Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

Medical School

Baylor College of Medicine, Houston, TX

Patient Care Philosophy

I believe that care for a cancer patients involves utilizing the latest and best medical science and treatments available. This often includes considering clinical trial participation, but also focusing on each patient as a unique individual with a unique medical history, concerns, and personal goals in order to formulate a treatment plan best tailored for each patient.

Additional Information

American Society of Clinical Oncology
American Society of Hematology